Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. (Q53269007)
Jump to navigation
Jump to search
scientific article published in April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. |
scientific article published in April 2005 |
Statements
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. (English)
1 reference
Harald Hampel
1 reference
Stefan J Teipel
1 reference
Hans-Jürgen Möller
1 reference
Richard Dodel
1 reference
Sylvia Brettschneider
1 reference
Nils G Morgenthaler
1 reference
Christina Fischer-Schulz
1 reference
Katharina Bürger
1 reference
Yansheng Du
1 reference
Andreas Bergmann
1 reference
1 April 2005
1 reference
57
1 reference
7
1 reference
813-816
1 reference
Identifiers
1 reference